These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 6697677)

  • 1. Effect of caffeine on the oral absorption and disposition of quinidine.
    Zeller FP; Ueda CT; Wulf BG; Meyers DG
    Clin Pharm; 1984; 3(1):72-5. PubMed ID: 6697677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of P-glycoprotein in the intestinal absorption and clinical effects of morphine.
    Kharasch ED; Hoffer C; Whittington D; Sheffels P
    Clin Pharmacol Ther; 2003 Dec; 74(6):543-54. PubMed ID: 14663457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of quinidine with anticonvulsant drugs.
    Data JL; Wilkinson GR; Nies AS
    N Engl J Med; 1976 Mar; 294(13):699-702. PubMed ID: 1250281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of effect of dietary salt on prehepatic first-pass metabolism: effects of beta-blockade and intravenous salt loading.
    Fromm MF; Darbar D; Dell'Orto S; Roden DM
    J Pharmacol Exp Ther; 1999 Jul; 290(1):253-8. PubMed ID: 10381784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quinidine as a probe for the role of p-glycoprotein in the intestinal absorption and clinical effects of fentanyl.
    Kharasch ED; Hoffer C; Altuntas TG; Whittington D
    J Clin Pharmacol; 2004 Mar; 44(3):224-33. PubMed ID: 14973303
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of sucralfate on ibuprofen absorption in normal volunteers.
    Pugh MC; Small RE; Garnett WR; Townsend RJ; Willis HE
    Clin Pharm; 1984; 3(6):630-3. PubMed ID: 6548940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid elimination of quinidine in pediatric patients.
    Szefler SJ; Pieroni DR; Gingell RL; Shen DD
    Pediatrics; 1982 Sep; 70(3):370-5. PubMed ID: 7110810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic analysis of intravenously and orally administered quinidine in horses.
    McGuirk SM; Muir WW; Sams RA
    Am J Vet Res; 1981 Jun; 42(6):938-42. PubMed ID: 7283244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steady-state bioavailability of two sustained-release quinidine preparations: quinidine gluconate versus quinidine sulfate.
    Taggart WV; Holyoak W
    Clin Ther; 1983; 5(4):357-64. PubMed ID: 6871920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic and pharmacodynamic interactions between diltiazem and quinidine.
    Laganière S; Davies RF; Carignan G; Foris K; Goernert L; Carrier K; Pereira C; McGilveray I
    Clin Pharmacol Ther; 1996 Sep; 60(3):255-64. PubMed ID: 8841148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of effect of cimetidine on the metabolism of quinidine: effect on renal clearance.
    Hardy BG; Schentag JJ
    Int J Clin Pharmacol Ther Toxicol; 1988 Aug; 26(8):388-91. PubMed ID: 3220613
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition kinetics of dihydroquinidine following quinidine administration.
    Ueda CT; Williamson BJ; Dzindzio BS
    Res Commun Chem Pathol Pharmacol; 1976 Jun; 14(2):215-25. PubMed ID: 940955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of oral neomycin on the absorption of isoniazid, quinidine and sulphafurazole from the rat small intestine in situ.
    Venho VM; Koivuniemi A
    Arzneimittelforschung; 1982; 32(2):141-3. PubMed ID: 7199917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacology, pharmacokinetics, and behavioral effects of caffeine in horses.
    Greene EW; Woods WE; Tobin T
    Am J Vet Res; 1983 Jan; 44(1):57-63. PubMed ID: 6824226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral absorption kinetics of levetiracetam: the effect of mixing with food or enteral nutrition formulas.
    Fay MA; Sheth RD; Gidal BE
    Clin Ther; 2005 May; 27(5):594-8. PubMed ID: 15978308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relative bioavailability of various quinidine preparations in man after a single oral dose].
    Terhaag B; Gieszinger U
    Pharmazie; 1982 Dec; 37(12):848-50. PubMed ID: 7163373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacokinetic interactions of nifedipine and quinidine.
    Hippius M; Henschel L; Sigusch H; Tepper J; Brendel E; Hoffmann A
    Pharmazie; 1995 Sep; 50(9):613-6. PubMed ID: 7480098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetic and pharmacodynamic properties of multiple oral doses of sitagliptin, a dipeptidyl peptidase-IV inhibitor: a double-blind, randomized, placebo-controlled study in healthy male volunteers.
    Bergman AJ; Stevens C; Zhou Y; Yi B; Laethem M; De Smet M; Snyder K; Hilliard D; Tanaka W; Zeng W; Tanen M; Wang AQ; Chen L; Winchell G; Davies MJ; Ramael S; Wagner JA; Herman GA
    Clin Ther; 2006 Jan; 28(1):55-72. PubMed ID: 16490580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of effect of Chinese medicines on bioavailability of ofloxacin in healthy volunteers.
    Hasegawa T; Yamaki K; Nadai M; Muraoka I; Wang L; Takagi K; Nabeshima T
    Int J Clin Pharmacol Ther; 1994 Feb; 32(2):57-61. PubMed ID: 8004359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of meals and dosage-form modification on theophylline bioavailability from a 24-hour sustained-release delivery system.
    González MA; Straughan AB
    Clin Ther; 1994; 16(5):804-14. PubMed ID: 7859239
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.